Specific ACC markers (inhibin and calretinin) were negative in the first IHC determination, and positive, only for calretinin in some of the diffuse atypical cells in the reevaluation, so the sarcomatoid subtype of ACC was diagnosed. This evidence concerns the gene CALB2 and adrenal cortex carcinoma.